| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/2011 | CN101940559A Orally-taken solid preparation containing gastric mucosa protective agent and application thereof |
| 01/12/2011 | CN101940558A (-)-Epigallocatechin-3-gallate pill composition and application thereof |
| 01/12/2011 | CN101940557A Method for preparing fat-soluble vitamin freeze-dried powder injection |
| 01/12/2011 | CN101940556A Preparation method of diammonium glycyrrhizinate freeze-dried powder injection |
| 01/12/2011 | CN101940555A Method for preparing azithromycin freeze-dried powder injection for injection |
| 01/12/2011 | CN101940553A Folic acid-vincristine targeted and slow-released nano-microspheres, prepared method and application thereof |
| 01/12/2011 | CN101940552A Chinese medicament shikimic acid powder injection |
| 01/12/2011 | CN101940549A Flurbiprofen axetil medium-chain and long-chain fat emulsion and preparation method thereof |
| 01/12/2011 | CN101940548A Oral fluorouracil emulsion and preparation method thereof |
| 01/12/2011 | CN101940547A Method for preparing ibuprofen injection |
| 01/12/2011 | CN101940540A Cosmetic and/or dermatological composition |
| 01/12/2011 | CN101632672B Compound medicinal composition for treating hypertension |
| 01/12/2011 | CN101612401B Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 01/12/2011 | CN101584694B Peptide deformylase inhibitor containing 2, 5-dihydropyrrole and synthesizing method |
| 01/12/2011 | CN101554378B Pharmaceutical composition containing prasugrel |
| 01/12/2011 | CN101554375B Pharmaceutical composition containing clopidogrel and carbazochrome sodium sulfonate |
| 01/12/2011 | CN101548955B Florfenicol lung targeting microspheres for animals and method for preparing same |
| 01/12/2011 | CN101543589B Compound pharmaceutical composition for curing virus diseases of animals and preparation method thereof |
| 01/12/2011 | CN101537146B Chinese medicine for treating carcinoma of colon |
| 01/12/2011 | CN101518531B Analgesic anti-inflammatory composite medicament and method for preparing same |
| 01/12/2011 | CN101513530B Polyhydroxyalkanoate (PHA) targeted carrier, drug-loading nano-particle and preparation methods and application thereof |
| 01/12/2011 | CN101513395B Taxol double-layer soft capsule oral preparation medicament |
| 01/12/2011 | CN101507748B External medicine liquor for treating common cold and preparation method thereof |
| 01/12/2011 | CN101497623B Compound containing imidazopyridine |
| 01/12/2011 | CN101492464B Sulfhydryl imidazopyridine derivative containing dioxepane-pyridine |
| 01/12/2011 | CN101492463B Imidazopyridine derivative containing dioxane-pyridine |
| 01/12/2011 | CN101461824B Solution for eliminating hemorrhoids |
| 01/12/2011 | CN101456871B Cephalosporin derivative containing mercaptothiazole |
| 01/12/2011 | CN101450927B Benzoic acid derivates containing oxo pyridine substituted propionamido |
| 01/12/2011 | CN101450044B Anti-coccidium suspension agent containing nicarbazin and preparation technique thereof |
| 01/12/2011 | CN101450041B Nano lycorine chloride microcapsule latex and preparation method thereof |
| 01/12/2011 | CN101439040B Medical use of 2-O-alpha-L-rhamnose-4,6,4'-trihydroxybenzophenone |
| 01/12/2011 | CN101426490B Compositions comprising alpha-ketoglutarate and their use for modulating muscle performance |
| 01/12/2011 | CN101416948B Quetiapine fmarate dispersible tablets |
| 01/12/2011 | CN101412717B Carbapenem derivative containing guanidyl alkanoylamino heterocycle |
| 01/12/2011 | CN101391039B Traditional Chinese medicine ointment for treating burn and preparation method thereof |
| 01/12/2011 | CN101367817B Carbpenem compound containing cyclohexenone formamido group |
| 01/12/2011 | CN101367807B Sulfhydryl pyrrolidine formamido pyridine substituted penem derivant |
| 01/12/2011 | CN101367801B Preparation method for pyrrol-hexahydric N heterocycle hydroxyl morpholine derivants, and medical uses thereof |
| 01/12/2011 | CN101366723B Medicinal composition |
| 01/12/2011 | CN101366717B Medicament formulation for treating condyloma acuminata |
| 01/12/2011 | CN101362763B Carbapenem derivates containing sulfhydryl pyrrolidine |
| 01/12/2011 | CN101357921B New dipeptidase-IV inhibitor compound |
| 01/12/2011 | CN101357920B Penem derivative containing sulfhydryl pyrrolidine formamido triazine |
| 01/12/2011 | CN101352443B Male-sterilant for mammalian |
| 01/12/2011 | CN101351204B Novel arylamidine derivative, salt thereof and antifungal agent containing those |
| 01/12/2011 | CN101343271B Penem derivant containing isoxazole alkyl ketone |
| 01/12/2011 | CN101343268B Thiazole couplet pyrazolone series compound and application of the same as Bcl-2 family protein antagonist |
| 01/12/2011 | CN101328179B Sulfhydryl pyrrolidine penem derivates containing oxo aza ring |
| 01/12/2011 | CN101327214B Medicine use of isoquinoline alkaloids as tissue factor inhibitor |
| 01/12/2011 | CN101322764B External use medicament for treating hyperosteogeny of cervical vertebra and lumbar principally and preparation thereof |
| 01/12/2011 | CN101292971B Use of chicoric acid in preparing medicaments for treating dementia diseases |
| 01/12/2011 | CN101288677B Puerarin derivatives powder injection and its production method |
| 01/12/2011 | CN101288649B Preparation technique of sodium phosphocreatine powder and injection preparation |
| 01/12/2011 | CN101277699B Sustained-release preparation |
| 01/12/2011 | CN101277689B Thiazolopyrimidine kinase inhibitors |
| 01/12/2011 | CN101273014B 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission |
| 01/12/2011 | CN101269079B Emulsion composition comprising prostaglandin E1 |
| 01/12/2011 | CN101262868B Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof |
| 01/12/2011 | CN101260112B Acethydrazide derivatives containing thieno[3.2-c]pyridine, preparation method and use thereof |
| 01/12/2011 | CN101260040B 5/7/6 type taxane diterpenoid, and medicament composition, synthesizing method and use thereof |
| 01/12/2011 | CN101254249B Chinese and Western compound preparations for curing cough and abundant sputum symptoms and method of preparing the same |
| 01/12/2011 | CN101250207B Canton love-pea vine total flavone c-glycosides effective part, preparation method and use thereof |
| 01/12/2011 | CN101240007B Oleanane triterpene compound with containing multiple unsaturated double bonds and use thereof |
| 01/12/2011 | CN101239187B Functionalization carbon nano-tube for tumor lympha targeted therapeutic carrier |
| 01/12/2011 | CN101239109B Externally-applied plaster for eliminating bony spur and preparation technique |
| 01/12/2011 | CN101204386B Liquid composite containing salbutamol sulfate and ambroxol hydrochloride |
| 01/12/2011 | CN101203227B Ergotrophic lactone compound |
| 01/12/2011 | CN101190906B Method for preparing carthamin yellow carthamus B and application thereof |
| 01/12/2011 | CN101185728B Infusion medicine for treating tinea unguium |
| 01/12/2011 | CN101152548B Medicine for treating gastropathy |
| 01/12/2011 | CN101137359B Methods of treating ear infections |
| 01/12/2011 | CN101094851B Novel compound having lipase inhibitory activity |
| 01/12/2011 | CN101087789B Pyridine imidazoles and aza-indoles as progesterone receptor modulators |
| 01/12/2011 | CN101084913B Application of ophiopognin saponin D in preparing vascular endothelial cells regulating signal transduction gene medicine |
| 01/12/2011 | CN101081848B Novel polyenes and preparation method and usage thereof |
| 01/12/2011 | CN101076354B Carrier used for medicine giving for intestine |
| 01/12/2011 | CN101076340B GABA-steroid antagonists and their use for the treatment of cns disorders |
| 01/12/2011 | CN101050216B Method for synthesizing medication Entecavir of anti hepatitis B |
| 01/12/2011 | CN101045721B Preparation of porcelain vine element unsaturated sodium salt and its application |
| 01/12/2011 | CN101043822B Composition containing fermentable polysaccharides |
| 01/12/2011 | CN101032551B Hepatosis-treating Chinese traditional medicine |
| 01/12/2011 | CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives |
| 01/12/2011 | CN101020719B Composite angelica polysaccharide and its preparation process and use |
| 01/12/2011 | CN101019952B Medicine for treating eczema and preparation process of its ointment |
| 01/12/2011 | CN101010276B Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 01/11/2011 | US7868225 Artichoke hybrid named ‘PS-H2015’ |
| 01/11/2011 | US7868206 2-amino-N-benzyl-4-(trifluoromethylthio)butanamide, used for the treatment or prevention of infectious diseases caused by protozoa or bacterium; therapeutic drugs for entamebiasis or trichomoniasis |
| 01/11/2011 | US7868205 N-[2-amino-5-(2-thienyl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide; antiproliferative, antiprotozoal agent; lymphoma, lung cancer, colon cancer, prostrate cancer, stomach cancer, breast cancer, leukemia |
| 01/11/2011 | US7868204 Inhibitors of histone deacetylase |
| 01/11/2011 | US7868193 Contraceptives; hormone replacement therapy |
| 01/11/2011 | US7868181 Compounds |
| 01/11/2011 | US7868177 protein kinase inhibitors such as N-(4-((3-(2-(methylamino)-4-pyrimidinyl)-2-pyridinyl)oxy)-1-naphthalenyl)-1H-benzimidazol-2-amine, used for the treatment of breast cancer or rheumatoid arthritis; anticarcinogenic agents; antiarthritic agents |
| 01/11/2011 | US7868176 Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-y1)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 01/11/2011 | US7868175 Biphenyl compounds useful as muscarinic receptor antagonists |
| 01/11/2011 | US7868173 Prodrugs of benzoquinolizine-2-carboxylic acid |
| 01/11/2011 | US7868172 2-(hetero)-aryl substituted tetrahydroquinoline derivatives |
| 01/11/2011 | US7868168 High viscosity xanthan polymer preparations |
| 01/11/2011 | US7868164 Cellulose ethers |
| 01/11/2011 | US7868163 Isomers of the dinucleotide Ap2A; incubating cADPR or NAD+ with adenine in the presence of ADP-ribosyl cyclase at a neutral pH; enzymatic assay; leukemia or lymphoma |